Fish Oil Drug Vascepa Looks Heart Healthy—But Is It Really? – The Daily Beast

Read article - Cites comments by Steven Woloshin, professor of The Dartmouth Institute for Health Policy and Clinical Practice, medicine, and community and family medicine, in an article about biopharma company Amarin's claims that its clinical trial results for the Vascepa show that it could transform heart disease prevention. Woloshin noted that the trial focused on patients who had high triglyceride levels, a history of heart disease or another elevated risk, and were already taking statins, meaning that the benefits of the drug are focused on a specific population.